治疗药物管道 管道
Lauren Sauer1, Alice Sato2, Herbert Dele Davies3
1GCHS, Special Pathogen Research Network, Department of Environmental, Agricultural and Occupational Health, UNMC College of Public Health, 984355 Nebraska Medical Center, Omaha, NE, USA.
Pediatric clinics of North America
|May 16, 2024
概括
为儿童开发医疗对策 (MCMs) 面临着独特的挑战,因为他们的独特需求. 2019年新冠肺炎疫情加快了对强大的儿科MCM管道的需求.
科学领域:
- 儿科药理学 儿科药理学
- 传染病治疗方法 传染病治疗方法
- 公共卫生准备 公共卫生准备
背景情况:
- 儿童具有独特的生理,发育和心理社会特征,使治疗发展复杂化.
- 流行病和疫情情情景加剧了创建有效的儿科医学对策 (MCMs) 的挑战.
- 过去十年已经取得了进展,但2019年新冠肺炎疫情凸显了儿科MCM发展的关键差距.
研究的目的:
- 为儿童群体开发医疗对策 (MCMs) 应对固有的挑战.
- 强调为儿童提供专门的MCM管道的必要性.
- 突出在公共卫生紧急情况期间儿童治疗开发所需的独特考虑因素.
主要方法:
- 审查关于儿科药物开发和MCM的现有文献.
- 分析在卫生危机期间针对儿科患者群体的具体挑战.
- 检查由冠状病毒疾病2019年大流行所推动的进展.
主要成果:
- 儿科特有的生理和发育差异对MCM发育构成重大障碍.
- 流行病的紧急性质需要为儿科MCM量身定制的方法.
- 2019年新冠肺炎疫情强调了加快儿科MCM研究和开发的必要性.
结论:
- 针对儿科医学对策的强有力的管道对于有效的公共卫生反应至关重要.
- 解决儿童独特的脆弱性是治疗发展中至关重要的.
- 未来的努力必须在MCM的设计和实施中优先考虑儿科方面的考虑.
相关概念视频
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Drug Administration and Therapy Phases: Overview
451
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
451
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K


